文献速递肿瘤 PET/CT

[68Ga]Ga-Pentixafor PET/CT显像用于不同组织学亚型肺癌CXCR4受体的在体定位:与免疫化学技术定量受体密度的相关性

[68Ga]Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors' density by immunochemistry techniques.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-12-09

前瞻性纳入94例肺癌患者行[68Ga]Ga-Pentixafor PET/CT,并用免疫组化和流式细胞术定量CXCR4表达。小细胞肺癌SUVmax和MFI均显著高于非小细胞肺癌和肺神经内分泌肿瘤。SUVmax与MFI在鳞癌和腺癌中显著相关。PET/CT鉴别小细胞肺癌与非小细胞肺癌的灵敏度85.7%、特异度78.1%(ROC截断SUVmax=7.2)。

要点

  • 小细胞肺癌SUVmax和MFI显著高于非小细胞肺癌和肺神经内分泌肿瘤。
  • 腺癌SUVmax显著高于鳞癌和NOS亚型。
  • SUVmax与MFI在鳞癌和腺癌中显著相关,支持体内摄取特异性。

核心结论

  • [68Ga]Ga-Pentixafor PET/CT对肺癌CXCR4受体在体靶向具有高灵敏度和特异度,可用于疗效评估和基于CXCR4的放射性配体治疗开发。

研究设计与样本

  • 前瞻性纳入94例肺癌患者(77男:17女,平均年龄60.1±10.1岁),行[68Ga]Ga-Pentixafor PET/CT,并用免疫组化和流式细胞术分析CXCR4表达。

主要发现

  • 75/94(79.8%)为非小细胞肺癌,14例(14.9%)为小细胞肺癌,5例(5.3%)为肺神经内分泌肿瘤。
  • 所有肺癌类型PET(SUVmax)和流式细胞术(MFI)均显示CXCR4表达增高。
  • 小细胞肺癌平均SUVmax=10.3±5.0、平均MFI=349.0±99.0,显著高于非小细胞肺癌和肺神经内分泌肿瘤(p=0.005)。
  • 腺癌(n=16)平均SUVmax=8.0±1.9,显著高于鳞癌(n=54;6.2±2.1)和NOS亚型(n=5;5.8±1.5)(p=0.003)。
  • 鳞癌中SUVmax与MFI显著相关(r=0.697;p=001),腺癌中亦显著相关(r=0.538,p=0.031);小细胞肺癌(r=0.435,p=0.121)和神经内分泌肿瘤(r=0.747,p=0.147)中相关性不显著,可能因样本量小。

关键数值与推荐

  • PET/CT鉴别小细胞肺癌与非小细胞肺癌的灵敏度85.7%、特异度78.1%(ROC截断SUVmax=7.2)。
  • PET/CT鉴别腺癌与鳞癌的灵敏度87.5%、特异度71.4%(ROC截断SUVmax=6.7)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 小细胞肺癌和神经内分泌肿瘤中SUVmax与MFI相关性不显著,原文认为可能因样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: In vivo CXCR4 receptor quantification in different lung cancer (LC) sub-types using [68Ga]Ga-Pentixafor PET/CT and to study correlation with quantitative CXCR4 receptors' tissue density by immunochemistry analyses. METHODS: [68Ga]Ga-Pentixafor PET/CT imaging was performed prospectively in 94 (77 M: 17F, mean age 60.1 ± 10.1 years) LC patients. CXCR4 receptors' expression on lung mass in all the patients was estimated by immunohistochemistry (IHC) and fluorescence-activated cell sorting (FACS) analyses. SUVmax on PET, intensity score on IHC, and mean fluorescence index (MFI) on FACS analyses were measured. RESULTS: A total of 75/94 (79.8%) cases had non-small cell lung cancer (NSCLC), 14 (14.9%) had small cell lung cancer (SCLC), and 5 (5.3%) had lung neuroendocrine neoplasm (NEN). All LC types showed increased CXCR4 expression on PET (SUVmax) and FACS (MFI). However, both these parameters (mean SUVmax = 10.3 ± 5.0; mean MFI = 349.0 ± 99.0) were significantly (p = 0.005) higher in SCLC as compared to those in NSCLC and lung NEN. The mean SUVmax in adenocarcinoma (n = 16) was 8.0 ± 1.9 which was significantly (p = 0.003) higher than in squamous cell carcinoma (n = 54; 6.2 ± 2.1) and in not-otherwise specified (NOS) sub-types (n = 5; 5.8 ± 1.5) of NSCLC. A significant correlation (r = 0.697; p = 001) was seen between SUVmax and MFI values in squamous cell NSCLC as well as in NSCLC adenocarcinoma (r = 0.538, p = 0.031) which supports the specific in vivo uptake of [68Ga]Ga-Pentixafor by CXCR4 receptors. However, this correlation was not significant in SCLC (r = 0.435, p = 0.121) and NEN (r = 0.747, p = 0.147) which may be due to the small sample size. [68Ga]Ga-Pentixafor PET/CT provided good sensitivity (85.7%) and specificity (78.1%) for differentiating SCLC from NSCLC (ROC cutoff SUVmax = 7.2). This technique presented similar sensitivity (87.5%) and specificity (71.4%) (ROC cutoff SUVmax = 6.7) for differentiating adenocarcinoma and squamous cell variants of NSCLC. CONCLUSION: The high sensitivity and specificity of [68Ga]Ga-Pentixafor PET/CT for in vivo targeting of CXCR4 receptors in lung cancer can thus be used effectively for the response assessment and development of CXCR4-based radioligand therapies in LC.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Watts A, Singh B, Singh H, et al. [68Ga]Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors' density by immunochemistry techniques. Eur J Nucl Med Mol Imaging. 2022. PMID: 36482077. doi:10.1007/s00259-022-06059-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。